SARAH CROOK: Open Payments
NPI 1871908483 · BROOKLAND, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$343 in 19 payments from 7 companies in 2025. Trend: 2023 $225 · 2024 $439 · 2025 $343
Food & beverage: $343
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $121 |
| Sumitomo Pharma America, Inc. | 2 | $50 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| Lilly USA, LLC | 2 | $39 |
| Phathom Pharmaceuticals, Inc. | 3 | $39 |
| ABBVIE INC. | 2 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: Ozempic, GEMTESA, MOUNJARO, VOQUEZNA, AIRSUPRA, UBRELVY, BREZTRI, Wegovy.
Industry payments across AR — which companies pay providers there.
